THERAZONE ApS — Credit Rating and Financial Key Figures
CVR number: 27255574
Nordvænget 9, 2791 Dragør
tel: 31770000
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 114.82 | - 101.85 | -82.90 | - 198.96 | - 255.95 |
| Employee benefit expenses | - 162.12 | - 171.33 | - 144.15 | - 180.55 | - 141.93 |
| Total depreciation | -14.33 | -20.53 | -20.53 | -15.42 | -14.47 |
| EBIT | - 291.26 | - 293.71 | - 247.58 | - 394.93 | - 412.36 |
| Other financial income | 11 190.35 | 1 797.44 | 928.69 | 4 508.02 | 5 644.60 |
| Other financial expenses | -51.33 | -74.52 | -4 337.18 | -16.82 | - 414.60 |
| Net income from associates (fin.) | 416.36 | 289.29 | 670.97 | - 731.72 | 249.60 |
| Pre-tax profit | 11 264.13 | 1 718.51 | -2 985.10 | 3 364.55 | 5 067.24 |
| Income taxes | -2 052.45 | - 342.22 | 806.57 | - 901.74 | -1 063.43 |
| Net earnings | 9 211.68 | 1 376.29 | -2 178.53 | 2 462.81 | 4 003.81 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 70.95 | ||||
| Machinery and equipment | 50.42 | 29.90 | 14.47 | ||
| Tangible assets total | 70.95 | 50.42 | 29.90 | 14.47 | |
| Holdings in group member companies | 289.29 | 960.25 | 228.53 | 478.13 | |
| Investments total | 289.29 | 960.25 | 228.53 | 478.13 | |
| Non-current loans receivable | 4 898.11 | 5 095.54 | 5 195.54 | 6 720.54 | 1 798.82 |
| Long term receivables total | 4 898.11 | 5 095.54 | 5 195.54 | 6 720.54 | 1 798.82 |
| Inventories total | |||||
| Current trade debtors | 125.00 | 255.00 | |||
| Current amounts owed by group member comp. | 5 243.27 | 17 604.98 | 16 222.30 | 10 080.00 | 85.60 |
| Prepayments and accrued income | 3.12 | ||||
| Current other receivables | 14.83 | 650.00 | 1 525.00 | 25.92 | 47.82 |
| Current deferred tax assets | 256.87 | 315.77 | 734.21 | 5.71 | 6.67 |
| Short term receivables total | 5 643.10 | 18 825.75 | 18 481.51 | 10 111.63 | 140.08 |
| Other current investments | 32 624.24 | 20 911.20 | 17 809.66 | 26 326.26 | 42 284.19 |
| Cash and bank deposits | 2 445.98 | 1 882.47 | 664.22 | 1 954.14 | 988.60 |
| Cash and cash equivalents | 35 070.22 | 22 793.68 | 18 473.88 | 28 280.40 | 43 272.79 |
| Balance sheet total (assets) | 45 682.38 | 47 054.68 | 43 141.08 | 45 355.57 | 45 689.82 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 113.00 | 114.40 | 117.80 | 4 000.00 | 2 000.00 |
| Other reserves | 263.78 | 934.75 | 203.03 | 452.63 | |
| Retained earnings | 34 073.25 | 42 906.74 | 43 494.27 | 38 047.46 | 38 260.67 |
| Profit of the financial year | 9 211.68 | 1 376.29 | -2 178.53 | 2 462.81 | 4 003.81 |
| Shareholders equity total | 43 522.93 | 44 786.22 | 42 493.29 | 44 838.30 | 44 842.10 |
| Provisions | 16.30 | ||||
| Non-current liabilities total | |||||
| Short-term capital loans | 413.70 | ||||
| Current loans from credit institutions | 0.37 | ||||
| Current trade creditors | 16.54 | 28.43 | 20.67 | 37.67 | 30.00 |
| Current owed to participating | 32.61 | 1 564.43 | |||
| Short-term deferred tax liabilities | 2 079.64 | 616.98 | 301.20 | 581.54 | |
| Other non-interest bearing current liabilities | 13.99 | 58.62 | 213.42 | 178.40 | 236.17 |
| Current liabilities total | 2 143.15 | 2 268.46 | 647.79 | 517.27 | 847.71 |
| Balance sheet total (liabilities) | 45 682.38 | 47 054.68 | 43 141.08 | 45 355.57 | 45 689.82 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.